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The mechanism by which yeast rus2 mutant hyperaccumulates glycogen has been investigated. Total glycogen synthase activity WHS between 2.5 
and 1.3 times higher in the rus2 mutant than in an isogenic strain. In addition, while in the normal strain the glycogen synthase activation state 
decreased along the exponential phase, in the mutant strain the opposite behaviour was observed: glycogen synthase activation state rose 
continuously reaching full activation at the beginning of the stationary phase. Glycogen phosphorylase a activity was up to 40 times higher in the 
mutant than in the normal strain. Glucose 6-phospha’te and fructose 2,G-bisphosphate l vels were slightly more elevated in the mutants. The increase 
in total glycogen synthase and, particularly, the full activation of this enzyme may explain glycogen hyperaccumulation in the rus2 mutant even 
in the presence of elevated levels of glycogen phosphorylase a. 
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I. INTRODUCTION 
The yeast Saccharomyces cerevisae contains two 
genes, RASZ and AAS.2, which encode proteins highly 
homologous to the mammalian WAS proteins [l-3]. 
Strains lacking RAS2 sporulate on rich media and 
hyperaccumulate glycogen 14-61. 
In yeast, RAS proteins control adenylate cyclase 
[4,7,8]. Compared to wild-type strains, adenylate cy- 
clase is significantly depressed in rtls2 mutants and these 
cells maintain very low levels of cAMP. The main role 
of cAMP appears to be the activation of cAMP-depen- 
dent protein kinases. Phosphorylation of specific sub- 
strates by these kinases controls cell metabolism and cell 
growth [6,9, lo]. 
Glycogen metabolism is controlled by the activity of 
glycogen synthase and glycogen phosphorylase. Both 
enzymes are regulated by phosphorylation and dephos- 
phorylation reactions (1 l-161. While phosphorylation 
activates phosphorylase and inactivates synthase, de- 
phosphorylation provokes the opposite effects. Several 
reports indicate that CAMP-dependent protein kinases 
are involved in the control of these enzvmatic activities 
in yeast [17,18]. 
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2.3. Preparation of cell-free exwuctsJor enzytne ussays 
Samples, all containing equal amounts of cells, were collected du- 
ring the period of growth of the culture. The volume required was 
determined by a calibration curve (dry weight vs absorbance). 
To obtain cell-free extracts, yeast cells (ca. 30 mg dry weight) were 
harvested by vacuum filtration, washed with cold distilled water, and 
suspended in 500 ,uI of buffer containing SO mM Tris-HCI (pH 7.0), 
25 mM KF, 0.5 mM phenylmethylsulfonyl fluoride and 1 mM /?- 
mercaptoethanol. The suspension was homogenized with 500 mg glass 
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The aim of this work was to study whether changes 
in the activity of glycogen synthase and glycogen phos- 
phorylase could reflect the decrease in the CAMP-de- 
pendent phosphorylation activity, which is a direct con- 
sequence of the low CAMP levels present in ras2 
mutants, and whether these changes in activity could, 
in turn, account for the accumulation of glycogen. 
2. MATERIAL AND METHODS 
2. I. Strains 
Succharomyces cerevisiae 547 (01 leu2 ura3-52 his4-539) and 546 (a 
leu2 uru3-52 his4-5.39 ras2-530::LEU2), a ras2 mutant derived from 
strain 547 were used for these experiments (both kindly provided by 
Dr K. Tatchell). 
2.2. GrowlIt condiGons 
Yeast cells were grown on an orbital shaker at 200 rpm at 30°C in 
a medium containing 2% glucose, 1% yeast extract and 1% bactopep- 
tone, The media were inoculated with yeasts grown to the stationary 
phase in the same medium. Growth was monitored by measuring the 
turbidity of the culture at 660 nm and samples were started to be 
collected when absorbance reached 0.5 (about I6 h after inoculation 
of medium). 
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beads (0.5 mm diameter) and vigorously shaken for five periods of 1 
min with 1 min intervals. During the idle intervals tubes were placed 
in ice [19]. The resulting homogenate was centrifuged at 1000 x g for 
15 min at 4°C and supematants were used for enzyme assays and 
protein determination. 
2.4. Preparation of cell-free extracts$or metabolite determinations 
Cell suspensions were rapidly harvested by vacuum filtration and 
the yeast pellicle was immediately immersed in liquid nitrogen. Acid 
extracts were obtained by mixing the feozen cells (about 30 mg dry 
weight) with 1 ml 10% perchloric acid in a mortar precooled with 
liquid niteogen, essentially as described in [ZO]. For the preparation of 
alkaline extracts, frozen cells (15 mg dry weight) were suspended in 
1 ml cold 54 mM NaOH. The suspension was incubated at 80°C for 
15 min. The supernatant obtained by centrifugation at 12 000 rpm in 






2.5. Enzyme assays 
Thd glycogeii synthase activity was measured as described in [21]. 
The assay mixture contained 4.4 mM UDP-[t4C]glucose (200 cpm/ 
nmol), 0.66% glycogen, 13 mM EDT& 25 mM KF, 50 mM Tris-HCI 
(pH 7.8) and 7,2 mM glusose 6-P. 
Active form of glycogen phosphorylase (phosphorylase a) was 
measured following the procedure described in [22]. The assay mixture 
contained 142 mM KF, 0.66% glycogen, 66.6 mM [‘4C]glucose I-P(30 
cemlnmoi). 10 mM caffeine and 10 mM EDTA at pH 6.3. 
_ All assays weee performed at 30°C. One unit is the amount of 
enzyme that catalyses the incorporation of 1 pmol of [‘4C]glucose into 
glycogen per min under the assay conditions. 
2.6. Metabolites and glycogen determination 
Glycogen was determined enzymatically by the incubation of 100 
@I of the acid homogenate (previously neutralized with 5 M K,COJ) 
with lOO@ of 73 U/ml amyloglucosidase (Sigma Chemical Co., USA) 
in 0.4 M acetate (pH 4.8) at 50°C for 3 h. After the addition of 150 
,LA of 10% pemhloric acid and centrifugation at 22 000 x g for 15 min 
at 4”C, glucose was measured in the supernatant using hcxokinase and 
glucose 6-P dehydrogenase [23]. 
For measuring glucose 6-P, the acid extract was centrifuged at 
22 000 x g for 15 min at 4°C. The supernatant was neutralized with 
5 M K&O3 and kept in ice for 30 min. Glucose 6-P was measured in 
the supernatant after centrifugation at 22 000 xg by using glucose 6-P 
dehydrogenase [24]. Fructose-2,6-P, was measured in alkaline extracts 
as in [25]. Auxiliary enzymes were from Boehringer Mannheim (Ger- 
many). 
Time since inoculation (h) 
Fig. 1. Glycogen accumulation in wild-type (0) and ras2 mutant (@) 
strains during growth of the culture. The arrow indicates point 50: at 
this moment the concentration of glucose in the medium was de- 
creased to 50% of initial value. The stationary phase began three hours 
later. Represented values are mean C SE from 5-7 independent experi- 
merits. 
higher. Initially, the glycogen content was about 10 mg/ 
8; it started to rise before point 50 and attained levels 
around 60 mg/g which are about tenfold higher than in 
the isogenic strain (Fig. 1). 
3.2. Glycogen synthase activity 
In the wild-type strain, total glycogen synthase acti- 
vity rose from 1.7 to 4.4 mU/mg protein during the 
exponential phase and remained constant along the sta- 
tionary phase (Fig. 2, Panel A). With regard to the 
activation state of the enzyme, measured by the (-)glu- 
case 6-P/(+)glucose 6-P activity ratio [21], it decreased 
continuously along the growth of the culture. 
On the other hand, the mutant strain presented an 
initial total glycogen synthase specific activity of about 
4.5 mU/mg protein (2.6 times higher than the wild-type) 
2.7. Other determinations 
Protein was measured in buffered extracts using the Biuret method 
1261 with bovine serum albumin as a standard. 
(Fig. 2, Panel B). Specific activity rose to 6.6 mU/mg 
L &rcose in the culture medium was determined, after filtration of 
the cells, by the hexokinaseelglucose 6-P dehydrogenase method [23]. 
The point where the concentration of glucose in the medium reached 
50% of the initial concentration was defined as point 50. This point 
50 permits the identification of two parts in the exponential phase, 
before and after, and also allows a comparison between different 
experiments. 
3. RESULTS 
3.1. Glycogerz 6 0 
IG IG 20 22 24 26 
In the wild-type strain, glycogen levels remained low, _ “.l . 
16 16 20 22 24 26 
about 0.5 mg/g during the first part of exponential 
growth. When the concentration of glucose in the me- 
dium w-p LID reduced to one half (point 50), glycogen star- 
ted to accumulate. Values up to 6 mg/g were reached at 
the beginning of the stationary phase. 
Values determined in the ras2 mutant were much 
ill,le S~~LCL* Inoculation (LI) 
Fig. 2. Glycogen synthase activity in wild-type (panel A) and. ras2 
mutant (panel B) strains during the growth of the culture. Total glyco- 
gen synthase specific activity ((+)glucose 6-P) ( ) and specific activity 
of the active form ((-)glucose 6-P) (0) were determined. The (-/+)glu- 
case 6-P activity ratio is also represented (0). Values are mean + SE 
from 5-7 independent experiments. Arrows indicate point 50. 
FERS LETTERS September 199 1 
1 
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Fig. 3. Glycogen phosphorylase u activity in wild-type (0) and rust 
mutant (@) strains during the growth of the culture. Glycogen phos- 
phorylase u activity was measured during the growth culture. Values 
are mean + SE from 5-4 independent experiments. Arrows indicate 
point 50. 
protein and then slightly decreased at the beginning of 
the stationary phase (5.8 mU/mg protein). Opposite to 
what was observed in the wild-type strain, in the mutant 
strain the (-)glucose 6-P/(+)glucose 6-P activity ratio 
remained stable in the first part of the exponential 
growth, started to rise before point SO and increased up 
to values of about 0.85, which were attained in the 
stationary phase. This is the highest value we have 
measured in many yeast strains. 
3.3. Clycogen phosphorylase activity 
Active glycogen phosphorylase (phosphorylase a) in 
the wild-type strain was very low at the beginning, 
about 0.5 mU/mg protein; it increased along the second 
part of the exponential growth and reached values of 7.5 
mU/mg protein in the stationary phase (Fig. 3). 
In the mutant strain, glycogen phosphorylase a activi- 
ty was very high. Initial values were already about 19 
Time since inoculation (II) 
Fig. 5. Fructose-2,6-P, levels during growth in wild-type (0) and ros2 
mutant (6~) strains. Values are mean + SE from three independent 
experiments. Arrows indicate point 50. 
mU/mg protein and constantly increased along the 
growth of the culture, attaining 40 mU/mg protein in 
the stationary phase. 
3.4. GllKose 6-P 
Glucose 6-P levels were slightly higher in the mutant 
than in the wild-type strain (Fig. 4). In both cases, val- 
ues progressively decreased about 10 times along the 
growth of the culture. Initially, glucose 6-P levels were 
around 5 pmollg and, at the beginning of the stationary 
phase, they had decreased to values around 0.5 pmollg 
in both strains. 
3.5. Fructose-t,6-P2 
Fructose-2,6-P, levels in the mutant were higher 
(about two-fold) than those determined in the wild-type 
strain (Fig. 5). In both cases? values constantly de- 
creased along the cell growth reaching very low values 
(around 0.5 nmol/g) in the stationary phase. 
16 18 20 22 24 26 
Time since inoculation ih) 
Fig. 4. Glucose 6-P levels during the growth of the culture in wild-type 
(0) and vu&? mutant (@) strains. Values are mean i: SE from three 
independent experiments. Arrows indicate point 50 
40 
4. QISCUSSION 
There is ample evidence showing that CAMP plays an 
important role in the regulation of carbohydrate meta- 
bolism in yeast [10,27,28]. Direct evidence of the impor- 
tance of CAMP stems from mutants which have disor- 
ders in the production of CAMP. These mutants present 
alterations in glycogen accumulation. RAS2 proteins in 
yeast are involved in the production of CAMP [4,8,29]. 
Therefore, rus2 mutants maintain very low levels of 
CAMP and this results in the hyperaccumulation of gly- 
cogen [5]. 
Glycogen synthase and glycogen phosphorylase, the 
two key enzymes in the control of biosynthesis and 
degradation of glycogen, respectively, are regulated by 
phosphorylation and dephosphorylation mechanisms 
[1 l-161. There is also evidence that, in yeast, the activity 
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of these two enzymes is regulated by a mechanism invol- 
ving phosphorylation by a cAMPdependent protein 
kinase [17,18]. Therefore, it seemed logical to assume 
that in rust mutants the activity of these enzymes would 
be altered in such a way that would explain the observed 
hyperaccumulation of glycogen. 
not operate. An obvious candidate for such inhibition 
is glucose 6-P, since this compound is able to inhibit 
glycogen phosphorylase, in addition to activating gIy- 
cogen synthase. 
Our results confirm that rus2 mutants hyperaccumu- 
late glycogen [S]. At the beginning of the stationary 
phase, the mutant strain had glycogen levels ten times 
higher than its isogenic strain. In the normal strain, 
glycogen accumulation started when the concentration 
of glucose in the medium had decreased by one half. 
This had been observed previously in other strains 
[30,31]. It is worth noting that in the rusd mutant glyco- 
gen initiated its accumulation earlier, before cells had 
consumed 50% of initial glucose. This suggests a possi- 
ble alteration in the glucose signalling mechanism in this 
mutant. 
Fructose-%,6-P, concentrations were higher (about 
double) in ras2 mutants than in wild-type cells. This is 
not in accordance with the accepted activation of PFK- 
2 by a CAMP-dependent protein kinase in yeast cells 
[34]. Nevertheless, we have to mention that in other 
cases discrepancies between cAMP and PFK3 activity 
have been observed [35], suggesting that determinations 
other than cAMP-dependent protein kinase are able to 
regulate PFK-2 [35-371. 
Major differences in the activity of glycogen metabo- 
lizing enzymes between these two strains have been ob- 
served. Theoretically, glycogen phosphorylase should 
have been inactivated in a strain with a failure in the 
adenylate cyclase activity, and therefore, with low 
cAMP levels and with a low degree of protein phospho- 
rylation. I-Iowever, the active form of the glycogen de- 
grading enzyme was between 5 and 40 times higher in 
the rusk mutant than in the isogenic strain. This was 
highly unexpected since phosphorylase is not supposed 
to be very active in a strain that hyperaccumulates gly- 
cogen. In this context it is worth noting that a similar 
situation has been observed recently in mutants car- 
rying a disruption in the SIT4 gene, which in compari- 
son with isogenic strains also present higher phosphory- 
lase N activity [32] and hyperaccumulate glycogen (Clo- 
tet, J., unpublished results). Point mutations in the SIT4 
gene also induce hyperaccumulation of glycogen [33]. 
Two general conclusions might be derived from QUIT 
results: (1) cAMP may be involved in the expression of 
glycogen synthase and glycogen phosphorylase in yeast 
cells, since the specific activity of these two enzymes is 
concomitantly elevated in ras2 mutants; however, only 
in the case of glycogen synthase the activation state of 
the enzyme is in accordance to the low CAMP levels 
characteristic of ras2 mutants; and (2) glycogen synthes- 
is in yeast may occur in the presence of elevated levels 
of phosphorylase a under conditions where glycogen 
synthase is also highly active. The unique behaviour of 
glycogen synthase in rad mutants, of which the activa- 
tion state raises along with the culture attaining full 
activation, may explain the hyperaccumulation of gly- 
cogen in these mutants. 
On the other hand, total glycogen synthase activity 
was between 2.5 and 1.3 times higher in the mutant than 
in the wild-type strain, Moreover, when the activation 
state of glycogen synthase is taken into account, a com- 
pletely different pattern is observed. In the normal 
strain, glycogen synthase activity ratio, which was high 
at the beginning and steadily decreased along the expo- 
nential phase. In the mutant strain we observed the 
opposite behaviour: glycogen activity ratio rose conti- 
nuously, reaching values close to 0.85 at the end of the 
stationary phase. This is a remarkably high value and 
corresponds to a fully activated enzyme. This finding 
can be perfectly explained by the decrease in cAIvIP- 
dependent phosphorylation activity consequence of the 
ras2 mutation. The observed increase in the total 
amount of glycogen synthase and especially in its acti- 
vation state may explain the hyperaccumulation of gly- 
cogen observed in the ras2 mutants, Wowever, since 
glycogen phosphorylase is found to be highly active in 
the mutant strain we have to postulate that this enzyme 
ought to be inhibited in vivo, so that a futile cycle d,oes 
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